{"transactions":[{"id":915825,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2026-02-06T08:01:09.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":16600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":35155,"source":{"system":"sec-edgar","filing":"0001683168-26-000813","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316826000813/ownership.xml","form_type":"4"}},{"id":1040191,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $.0001 par value","published_at":"2025-09-15T08:29:58.000Z","date":"2025-09-11","kind":"grant","planned":false,"acquired":true,"shares":16200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of reported securities has been adjusted to reflect prior reverse stock splits."}],"balance_after":18555,"source":{"system":"sec-edgar","filing":"0001683168-25-006959","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316825006959/ownership.xml","form_type":"4"}},{"id":1408414,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-09-12T16:11:58.000Z","date":"2024-09-11","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest on the first anniversary of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001683168-24-006336","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316824006336/ownership.xml","form_type":"4"}},{"id":1712206,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Sciencific Officer"}}],"security":"Stock Options","published_at":"2023-12-13T17:30:10.000Z","date":"2023-12-11","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of December 11, 2023; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on March 11, 2025 and ending on December 11, 2026."}],"balance_after":10000,"derivative":{"exercise_price":3.88,"expiration_date":"2033-12-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-23-008825","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316823008825/ownership.xml","form_type":"4"}},{"id":1999046,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2023-02-22T19:30:12.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 26, 2023, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-12."}],"balance_after":3197,"source":{"system":"sec-edgar","filing":"0001209191-23-011942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000120919123011942/doc4.xml","form_type":"4"}},{"id":2316384,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Sciencific Officer"}}],"security":"Stock Options","published_at":"2022-03-28T17:13:39.000Z","date":"2022-03-24","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 24, 2022; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 24, 2023 and ending on March 24, 2025."}],"balance_after":50000,"derivative":{"exercise_price":1.12,"expiration_date":"2032-03-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001683168-22-002001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316822002001/ownership.xml","form_type":"4"}},{"id":2391369,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2022-02-16T20:12:03.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock underlying unvested restricted stock units."}],"balance_after":20366,"source":{"system":"sec-edgar","filing":"0001209191-22-010405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000120919122010405/doc4.xml","form_type":"4"}},{"id":2776045,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Sciencific Officer"}}],"security":"Stock Options","published_at":"2021-03-22T17:30:17.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 18, 2021; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 18, 2022 and ending on March 18, 2024."}],"balance_after":50000,"derivative":{"exercise_price":2.6,"expiration_date":"2031-03-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001683168-21-001020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316821001020/ownership.xml","form_type":"4"}},{"id":2811889,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, $0.0001 par value","published_at":"2021-03-03T21:05:22.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a\nratio of 1-for-55."}],"balance_after":10366,"source":{"system":"sec-edgar","filing":"0001209191-21-017571","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000120919121017571/doc4.xml","form_type":"4"}},{"id":3349433,"issuer":{"id":8008,"kind":"organization","name":"Xenetic Biosciences, Inc."},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Options","published_at":"2019-12-06T18:37:34.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options will vest and become exercisable as follows: 30,000 shares shall vest on the first anniversary of December 4, 2019 (\"Vesting Start Date\"); 30,000 shares shall vest on the second anniversary of the Vesting Start Date; and 30,000 shares shall vest on the third anniversary of the Vesting Start Date."}],"balance_after":90000,"derivative":{"exercise_price":1.31,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001683168-19-003919","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000168316819003919/ownership.xml","form_type":"4"}},{"id":3653313,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2019-02-15T21:09:48.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":20130,"source":{"system":"sec-edgar","filing":"0001209191-19-010828","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000120919119010828/doc4.xml","form_type":"4"}},{"id":3852859,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-03T21:37:06.000Z","date":"2018-08-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date."}],"balance_after":10130,"source":{"system":"sec-edgar","filing":"0001209191-18-045461","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000120919118045461/doc4.xml","form_type":"4"}},{"id":4467952,"issuer":{"id":7889,"kind":"organization","name":"Phio Pharmaceuticals Corp.","symbol":"PHIO"},"owners":[{"id":67395,"kind":"person","name":"Lockshin Curtis","position":1,"cik":"0001383556","reported_name":"Lockshin Curtis","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-02-03T17:24:07.000Z","date":"2017-02-01","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal quarterly installments over one year beginning on the first quarterly anniversary of the grant date."}],"balance_after":2000,"derivative":{"exercise_price":0.629,"expiration_date":"2027-02-01","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001209191-17-007746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1383556/000120919117007746/doc4.xml","form_type":"4"}}]}